The sustained hydrogen bond network and minimal structural drift corroborate its favorable binding energies (−5.4 and −5.1 kcal mol−1, respectively) and lend further credence to the PI3K/AKT pathway as a principal pharmacological target of cinnamic acid in hepatocellular carcinoma. The gene discussed is AKT1; the disease is hepatocellular carcinoma.